Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 15 results.
User Information
Export Records
  1. 1.   Engaging Anaphase Catastrophe Mechanisms to Eradicate Aneuploid Cancers
  2. Kawakami, Masanori; Mustachio, Lisa Maria; Liu, Xi; Dmitrovsky, Ethan
  3. Molecular Cancer Therapeutics. 2018, Apr; 17(4): 724-731.
  1. 2.   Hematopoiesis and thymic apoptosis are not affected by the loss of Cdk2
  2. Berthet, C.; Rodriguez-Galan, M. C.; Hodge, D. L.; Gooya, J.; Pascal, V.; Young, H. A.; Keller, J.; Bosselut, R.; Kaldis, P.
  3. Molecular and Cellular Biology. 2007, Jul; 27(14): 5079-5089.
  1. 3.   Transgenic expression of human thymidylate synthase accelerates the development of hyperplasia and tumors in the endocrine pancreas
  2. Chen, M.; Rahman, L.; Voeller, D.; Kastanos, E.; Yang, S. X.; Feigenbaum, L.; Allegra, C.; Kaye, F. J.; Steeg, P.; Zajac-Kaye, M.
  3. Oncogene. 2007, Jul; 26(33): 4817-4824.
  1. 4.   Homology model of the CDK1/cyclin B complex
  2. McGrath, C. F.; Pattabiraman, N.; Kellogg, G. E.; Lemcke, T.; Kunick, C.; Sausville, E. A.; Zaharevitz, D. W.; Gussio, R.
  3. Journal of Biomolecular Structure & Dynamics. 2005, APR; 22(5): 493-502.
  1. 5.   Lsh controls silencing of the imprinted Cdkn1c gene
  2. Fan, T.; Hagan, J. P.; Kozlov, S. V.; Stewart, C. L.; Muegge, K.
  3. Development. 2005, FEB; 132(4): 635-644.
  1. 6.   Effect of cell cycle inhibition on cisplatin-induced cytotoxicity
  2. Fishel, M. L.; Newell, D. R.; Griffin, R. J.; Davison, R.; Wang, L. Z.; Curtin, N. J.; Zuhowski, E. G.; Kasza, K.; Egorin, M. J.; Moschel, R. C.; Dolan, M. E.
  3. Journal of Pharmacology and Experimental Therapeutics. 2005, JAN; 312(1): 206-213.
  1. 7.   Induction of apoptosis by flavopiridol in human neuroblastoma cells is enhanced under hypoxia and associated with N-myc proto-oncogene down-regulation
  2. Puppo, M.; Pastorino, S.; Melillo, G.; Pezzolo, A.; Varesio, L.; Bosco, M. C.
  3. Clinical Cancer Research. 2004, DEC 15; 10(24): 8704-8719.
  1. 8.   Clinical pharmacology of flavopiridol following a 72-hour continuous infusion
  2. Rudek, M. A.; Bauer, K. S.; Lush, R. M.; Stinson, S. F.; Senderowicz, A. M.; Headlee, D. J.; Arbuck, S. G.; Cox, M. C.; Murgo, A. J.; Sausville, E. A.; Figg, W. D.
  3. Annals of Pharmacotherapy. 2003 37(10): 1369-1374.
  1. 9.   Phase I clinical and pharmacokinetic study of flavopiridol administered as a daily 1-hour infusion in patients with advanced neoplasms
  2. Tan, A. R.; Headlee, D.; Messmann, R.; Sausville, E. A.; Arbuck, S. G.; Murgo, A. J.; Melillo, G.; Zhai, S. P.; Figg, W. D.; Swain, S. M.; Senderowicz, A. M.
  3. Journal of Clinical Oncology. 2002 20(19): 4074-4082.
  1. 10.   Flavopiridol inhibits vascular endothelial growth factor production induced by hypoxia or picolinic acid in human neuroblastoma
  2. Rapella, A.; Negrioli, A.; Melillo, G.; Pastorino, S.; Varesio, L.; Bosco, M. C.
  3. International Journal of Cancer. 2002 99(5): 658-664.
  1. 11.   DNA demethylation reactivates a subset of imprinted genes in uniparental mouse embryonic fibroblasts
  2. El Kharroubi, A.; Piras, G.; Stewart, C. L.
  3. Journal of Biological Chemistry. 2001 276(12): 8674-8680.
  1. 12.   Promotion of S-Phase entry and cell growth under serum starvation by SAC/ROC2/Rbx2/Hrt2, an E3 ubiquitin ligase component: Association with inhibition of p27 accumulation
  2. Duan, H. J.; Tsvetkov, L. M.; Liu, Y. L.; Song, Y.; Swaroop, M.; Wen, R.; Kung, H. F.; Zhang, H.; Sun, Y.
  3. Molecular Carcinogenesis. 2001 30(1): 37-46.
  1. 13.   CAK-independent activation of CDK6 by a viral cyclin
  2. Kaldis, P.; Ojala, P. M.; Tong, L.; Makela, T. P.; Solomon, M. J.
  3. Molecular Biology of the Cell. 2001 12(12): 3987-3999.
  1. 14.   Structure-based design modifications of the paullone molecular scaffold for cyclin-dependent kinase inhibition
  2. Gussio, R.; Zaharevitz, D. W.; McGrath, C. F.; Pattabiraman, N.; Kellogg, G. E.; Schultz, C.; Link, A.; Kunick, C.; Leost, M.; Meijer, L.; Sausville, E. A.
  3. Anti-Cancer Drug Design. 2000 15(1): 53-66.
  1. 15.   Cloning and Chromosome Mapping of the Feline Genes P21waf1 and P27kip1
  2. Okuda, M.; Minehata, K.; Setoguchi, A.; Cho, K. W.; Nakamura, N.; Nishigaki, K.; Watari, T.; Cevario, S.; Obrien, S. J.; Tsujimoto, H.; Hasegawa, A.
  3. Gene. 1997 198(1-2): 141-147.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel